Last reviewed · How we verify

NCT04762914

Observing the Perioperative Effects of Prehabilitation in Colorectal Cancer Patients

Completed Last updated 21 February 2021
What this trial tests

trial testing Prehabilitation in Colon Cancer in 52 participants. Completed in 31 December 2019.

Timeline
1 September 2018
Primary endpoint
31 December 2019
31 December 2019

Quick facts

Lead sponsorMedway Primary Care Trust
StatusCompleted
Study typeOBSERVATIONAL
Enrollment52
Start date1 September 2018
Primary completion31 December 2019
Estimated completion31 December 2019
Sites1 location across United Kingdom

Drugs / interventions tested

Conditions studied

Sponsor

Medway Primary Care Trust

Who can join

18 and older, any sex, with Colon Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Quality Improvement Project to evaluate how prehabilitation can be incorporated into our colorectal cancer pathway and assess its clinical benefits.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Prehabilitation

Trials testing the same drug.

Other recruiting trials for Colon Cancer

Currently open trials in the same condition.

Other Medway Primary Care Trust trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04762914.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing